BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 30277049)

  • 1. [Not Available].
    Hompland I; Hølmebakk T; Boye K; Stoldt S; Bjerkehagen B; Berner JM; Wiedswang AM; Revheim ME; Poulsen JP; Hall KS; Bruland ØS
    Tidsskr Nor Laegeforen; 2018 Oct; 138(15):. PubMed ID: 30277049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Gastrointestinal stromal tumors (GIST)].
    Jaros D; Bozic B; Sebesta C
    Wien Med Wochenschr; 2023 Jun; 173(9-10):201-205. PubMed ID: 36155864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular pathology of gastrointestinal stromal tumors and implications for treatment and prognosis.
    Parkin B; Chugh R
    Curr Probl Cancer; 2011; 35(5):245-54. PubMed ID: 22118564
    [No Abstract]   [Full Text] [Related]  

  • 4. [The importance of mutational status in prognosis and therapy of GIST].
    Comandone A; Boglione A
    Recenti Prog Med; 2015 Jan; 106(1):17-22. PubMed ID: 25621775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of multiple gastrointestinal stromal tumors caused by a germline KIT gene mutation (p.Leu576Pro).
    Vale Rodrigues R; Santos F; Pereira da Silva J; Francisco I; Claro I; Albuquerque C; Lemos MM; Limbert M; Dias Pereira A
    Fam Cancer; 2017 Apr; 16(2):267-270. PubMed ID: 27771813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gastrointestinal stromal tumour (GIST): current standards in multimodal management].
    Reichardt P; Reichardt A
    Zentralbl Chir; 2011 Aug; 136(4):359-63. PubMed ID: 21863513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant KIT/BRAF and PDGFRA/BRAF mutations are rare events in gastrointestinal stromal tumors.
    Rossi S; Sbaraglia M; Dell'Orto MC; Gasparotto D; Cacciatore M; Boscato E; Carraro V; Toffolatti L; Gallina G; Niero M; Pilozzi E; Mandolesi A; Sessa F; Sonzogni A; Mancini C; Mazzoleni G; Romeo S; Maestro R; Dei Tos AP
    Oncotarget; 2016 May; 7(21):30109-18. PubMed ID: 27097112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum miR-518e-5p is a potential biomarker for secondary imatinib-resistant gastrointestinal stromal tumor.
    Kou Y; Yang R; Wang Q
    J Biosci; 2018 Dec; 43(5):1015-1023. PubMed ID: 30541960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cytology genotyping of primary and metastatic GI stromal tumors by using a custom two-gene targeted next-generation sequencing panel with therapeutic intent.
    Gleeson FC; Kerr SE; Kipp BR; Voss JS; Minot DM; Tu ZJ; Henry MR; Vasmatzis G; Cheville JC; Lazaridis KN; Levy MJ
    Gastrointest Endosc; 2016 Dec; 84(6):950-958.e3. PubMed ID: 27118626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrointestinal stromal tumour.
    Joensuu H; Hohenberger P; Corless CL
    Lancet; 2013 Sep; 382(9896):973-83. PubMed ID: 23623056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Case of Disseminated Intra-abdominal Gastrointestinal Stromal Tumor Managed with Low Dose Imatinib.
    Jang BH; Kim BW; Lim KJ; Kim BG; Park SM; Kim JS; Ji JS; Choi H
    Korean J Gastroenterol; 2015 Jun; 65(6):366-9. PubMed ID: 26087692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathology and molecular diagnostics of gastrointestinal stromal tumors.
    Lucas DR
    Curr Probl Cancer; 2011; 35(5):233-44. PubMed ID: 22118563
    [No Abstract]   [Full Text] [Related]  

  • 13. Knowns and Known Unknowns of Gastrointestinal Stromal Tumor Adjuvant Therapy.
    Martínez-Marín V; Maki RG
    Gastroenterol Clin North Am; 2016 Sep; 45(3):477-86. PubMed ID: 27546844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GEIS guidelines for gastrointestinal sarcomas (GIST).
    Poveda A; García Del Muro X; López-Guerrero JA; Cubedo R; Martínez V; Romero I; Serrano C; Valverde C; Martín-Broto J;
    Cancer Treat Rev; 2017 Apr; 55():107-119. PubMed ID: 28351781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of pathologists in the target therapy of gastrointestinal tumors].
    Liang ZY
    Zhonghua Bing Li Xue Za Zhi; 2010 Jul; 39(7):433-5. PubMed ID: 21055169
    [No Abstract]   [Full Text] [Related]  

  • 16. Classification of KIT/PDGFRA wild-type gastrointestinal stromal tumors: implications for therapy.
    Huss S; Elges S; Trautmann M; Sperveslage J; Hartmann W; Wardelmann E
    Expert Rev Anticancer Ther; 2015 Jun; 15(6):623-8. PubMed ID: 25831232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrointestinal stromal tumors: A multidisciplinary challenge.
    Sanchez-Hidalgo JM; Duran-Martinez M; Molero-Payan R; Rufian-Peña S; Arjona-Sanchez A; Casado-Adam A; Cosano-Alvarez A; Briceño-Delgado J
    World J Gastroenterol; 2018 May; 24(18):1925-1941. PubMed ID: 29760538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imatinib-Sensitizing KIT Mutation in a Carney-Stratakis-Associated GI Stromal Tumor.
    Gasparotto D; Rossi S; Campagna D; Scavina P; Tiziano FD; Marzotto A; Toffolatti L; Vitelli CE; Amini M; Dei Tos AP; Maestro R
    J Clin Oncol; 2016 Apr; 34(11):e99-e103. PubMed ID: 25547508
    [No Abstract]   [Full Text] [Related]  

  • 19. [Application and value of mutation detection in diagnosis and treatment of gastrointestinal stromal tumor].
    Cao H; Wang M
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar; 16(3):208-11. PubMed ID: 23536336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hedgehog pathway dysregulation contributes to the pathogenesis of human gastrointestinal stromal tumors via GLI-mediated activation of KIT expression.
    Tang CM; Lee TE; Syed SA; Burgoyne AM; Leonard SY; Gao F; Chan JC; Shi E; Chmielecki J; Morosini D; Wang K; Ross JS; Kendrick ML; Bardsley MR; Siena M; Mao J; Harismendy O; Ordog T; Sicklick JK
    Oncotarget; 2016 Nov; 7(48):78226-78241. PubMed ID: 27793025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.